NAUT Stock Analysis: Buy, Sell, or Hold?
NAUT - Nautilus Biotechnolgy, Inc. Common Stock
$1.75
-0.03 (-1.69%)
▼
5d:
+3.55%
30d:
-23.41%
90d:
-41.08%
BUY
HIGH Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Jul 28, 2026
12d
Get Alerted When NAUT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: NAUT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: NAUT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: NAUT is currently trading at $1.75, which is considered slightly low relative to its 30-day fair value range of $1.87 to $2.48.
Technical Outlook: Technically, NAUT is in a uptrend. The price is currently testing key support at $2.29. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.00 (+128.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NAUT is in a uptrend. The price is currently testing key support at $2.29. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.00 (+128.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.87 -
$2.48
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 128.6% below Wall St target ($4.00)
Trading Range Analysis
30-Day Trading Range
$1.87 -
$2.48
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.29
Resistance Level
$2.89
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.37
Wall Street Target
$4.00
(+128.6%)
Share & Embed Analysis
Last updated: July 15, 2026 3:14 AM ET
Data refreshes hourly during market hours. Next update: 4:14 AM
Data refreshes hourly during market hours. Next update: 4:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NAUT showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Sujal M Patel
BUY
25000 shares
2026-03-04
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 58 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 51 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$111 | 60 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 62 BUY |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$20 | 63 BUY |
Advanced NAUT Option Strategies
Professional options setups generated by AI based on today's NAUT price and gamma walls.
